Managing hyperglycaemia caused by steroid treatment for COVID-19

New tutorial available now

Dr Vinay Eligar, Consultant in Diabetes and Endocrinology within Cardiff & Vale University Health Board, who outlines the impact of COVID-19 on blood glucose control, the management of hyperglycaemia for patients on dexamethasone, and what happens when treatment is stopped and the patient is discharged from hospital.

© Institute of Clinical Science and Technology (ICST) 2020

Support: admin@clinicalscience.org.uk